Showing results (601-610 of 957) with videos related to
Sort By:
Pageof 96
Annals of Gastroenterological Surgery|January 5, 2026
Gastric Distension Index: A Novel Radiographic Marker Associated With Postoperative Gastric Stasis After GastrectomyHiroki Harada, Yoshiko Yamaoka, Akiko Watanabe, et al.Annals of Gastroenterological Surgery|January 5, 2026
Deep Learning Model for Predicting Operative Mortality After Total Gastrectomy: Analysis of the Japanese National Clinical Database (NCD)Ryosuke Fukuyo, Hiroyuki Yamamoto, Masanori Tokunaga, et al.Annals of Gastroenterological Surgery|January 5, 2026
Impact of Sarcopenia During Induction Treatment in Patients With Unresectable Locally Advanced Pancreatic CancerSho Uemura, Masayuki Tanaka, Minoru Kitago, et al.Annals of Gastroenterological Surgery|January 5, 2026
Essential Updates 2024/2025: History, Pathogenesis, Definition, Prevention, and Management of Small-for-Size Syndrome in Living-Donor Liver TransplantationToru Ikegami, Masashi Tsunematsu, Shinji Onda, et al.Annals of Gastroenterological Surgery|January 5, 2026
Potential Survival Benefit of Adjuvant Chemotherapy in Stage IV Intrahepatic Cholangiocarcinoma: A Multicenter, Stage-Stratified AnalysisHisashi Kosaka, Masaki Ueno, Hiroji Shinkawa, et al.Annals of Gastroenterological Surgery|January 5, 2026
Trends in Gender Disparities in Surgical Experience: A National Clinical Database StudyChie Tanaka, Hiroyuki Yamamoto, Sachiyo Nomura, et al.Annals of Gastroenterological Surgery|October 2, 2020
Laparoscopic repeat liver resectionZenichi MoriseAnnals of Gastroenterological Surgery|October 2, 2020
Current statement and safe implementation of minimally invasive surgery in the pancreasHiromitsu Hayashi, Hideo BabaAnnals of Gastroenterological Surgery|October 2, 2020
Prophylaxis of Crohn's disease recurrence: A surgeon's perspectiveDallas D Wolford, Alessandro FicheraAnnals of Gastroenterological Surgery|October 2, 2020
Primary results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for advanced gastric cancerTsutomu Hayashi, Takaki Yoshikawa, Kentaro Sakamaki, et al.Pageof 96